Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing.
Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing.
复制标题
DOI:
10.1038/ncb3378
复制
发表时间:
2016-07
影响因子:
21.3
通讯作者:
Gorgoulis VG
中科院分区:
文献类型:
--
作者:
Galanos P;Vougas K;Walter D;Polyzos A;Maya-Mendoza A;Haagensen EJ;Kokkalis A;Roumelioti FM;Gagos S;Tzetis M;Canovas B;Igea A;Ahuja AK;Zellweger R;Havaki S;Kanavakis E;Kletsas D;Roninson IB;Garbis SD;Lopes M;Nebreda A;Thanos D;Blow JJ;Townsend P;Sørensen CS;Bartek J;Gorgoulis VG
The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is the prototype downstream effector of the tumor suppressor protein p53. Yet, evidence from human cancer and mice models, imply that p21WAF1/Cip1, under certain conditions, can exercise oncogenic activity. The mechanism behind this behavior is still obscure. Within this context we unexpectedly noticed, predominantly in p53 mutant human cancers, that a subset of highly atypical cancerous cells expressing strongly p21WAF1/Cip1 demonstrated also signs of proliferation. This finding suggests either tolerance to high p21WAF1/Cip1 levels or that p21WAF1/Cip1 per se guided a selective process that led to more aggressive off-springs. To address the latter scenario we employed p21WAF1/Cip1-inducible p53-null cellular models and monitored them over a prolonged time period, using high-throughput screening means. After an initial phase characterized by stalled growth, mainly due to senescence, a subpopulation of p21WAF1/Cip1 cells emerged, demonstrating increased genomic instability, aggressiveness and chemo-resistance. At the mechanistic level unremitted p21WAF1/Cip1 production “saturates” the CRL4CDT2 and SCFSkp2 ubiquitin ligase complexes reducing the turn-over of the replication licensing machinery. Deregulation of replication licensing triggered replication stress fuelling genomic instability. Conceptually, the above notion should be considered when anti-tumor strategies are designed, since p21WAF1/Cip1 responds also to p53-independent signals, including various chemotherapeutic compounds.
登录
查看更多内容
DOI:
10.1083/jcb.200905059
发表时间:
2010-03-08
期刊:
The Journal of cell biology
影响因子:
--
作者:
Beck H;Nähse V;Larsen MS;Groth P;Clancy T;Lees M;Jørgensen M;Helleday T;Syljuåsen RG;Sørensen CS
通讯作者:
Sørensen CS
影响因子:
64.8
作者:
Bartkova, Jirina;Rezaei, Nousin;Gorgoulis, Vassilis G.
通讯作者:
Gorgoulis, Vassilis G.
影响因子:
64.5
作者:
Barlow JH;Faryabi RB;Callén E;Wong N;Malhowski A;Chen HT;Gutierrez-Cruz G;Sun HW;McKinnon P;Wright G;Casellas R;Robbiani DF;Staudt L;Fernandez-Capetillo O;Nussenzweig A
通讯作者:
Nussenzweig A
影响因子:
16.8
作者:
Hanada, Katsuhiro;Budzowska, Magda;Kanaar, Roland
通讯作者:
Kanaar, Roland
影响因子:
12.4
作者:
Evangelou, K.;Bartkova, J.;Gorgoulis, V. G.
通讯作者:
Gorgoulis, V. G.